SIMILAR PATTERNS OF AMINO ACIDS FOR 2NMZ_B_ROCB401_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 LEU E  30
ASP E  32
GLY E  34
ASP E  37
ILE E 120
None
0.47A 2nmzA-1cziE:
6.8
2nmzA-1cziE:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ee1 NH(3)-DEPENDENT
NAD(+) SYNTHETASE


(Bacillus
subtilis)
PF02540
(NAD_synthase)
6 LEU A  43
GLY A  48
ASP A  89
PRO A  99
ALA A  76
ILE A  45
ATP  A5000 (-4.7A)
ATP  A5000 (-3.7A)
None
None
None
None
1.50A 2nmzA-1ee1A:
undetectable
2nmzA-1ee1A:
17.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ez4 LACTATE
DEHYDROGENASE


(Lactobacillus
pentosus)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
6 LEU A 321
ASP A 141
GLY A 162
ILE A 189
ALA A 318
ILE A 287
None
1.40A 2nmzA-1ez4A:
undetectable
2nmzA-1ez4A:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1f3l PROTEIN ARGININE
METHYLTRANSFERASE
PRMT3


(Rattus
norvegicus)
PF06325
(PrmA)
6 LEU A 287
ASP A 282
GLY A 260
ILE A 226
ILE A 265
ILE A 286
None
SAH  A 529 (-2.7A)
SAH  A 529 (-3.1A)
None
SAH  A 529 (-4.9A)
None
1.35A 2nmzA-1f3lA:
undetectable
2nmzA-1f3lA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h74 HOMOSERINE KINASE

(Methanocaldococcus
jannaschii)
PF00288
(GHMP_kinases_N)
PF08544
(GHMP_kinases_C)
6 LEU A 112
GLY A  80
GLY A  65
ILE A  48
ALA A 108
ILE A 109
None
1.13A 2nmzA-1h74A:
undetectable
2nmzA-1h74A:
13.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ALA A  28
ASP A  29
ASP A  30
ILE A  84
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 (-3.8A)
A79  A 800 (-3.6A)
1.23A 2nmzA-1hvcA:
14.4
2nmzA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 (-3.6A)
A79  A 800 ( 3.9A)
A79  A 800 (-3.6A)
0.94A 2nmzA-1hvcA:
14.4
2nmzA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
1.00A 2nmzA-1hvcA:
14.4
2nmzA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
1.35A 2nmzA-1hvcA:
14.4
2nmzA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
1.35A 2nmzA-1hvcA:
14.4
2nmzA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  48
PRO A  81
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 (-3.6A)
A79  A 800 ( 3.9A)
1.48A 2nmzA-1hvcA:
14.4
2nmzA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-3.6A)
0.46A 2nmzA-1hvcA:
14.4
2nmzA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
0.48A 2nmzA-1hvcA:
14.4
2nmzA-1hvcA:
46.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1iay 1-AMINOCYCLOPROPANE-
1-CARBOXYLATE
SYNTHASE 2


(Solanum
lycopersicum)
PF00155
(Aminotran_1_2)
6 ALA A 144
ASP A 143
ILE A 232
ILE A 203
ALA A 188
ILE A 168
None
1.48A 2nmzA-1iayA:
undetectable
2nmzA-1iayA:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j17 TRYPSIN II, ANIONIC

(Rattus
norvegicus)
PF00089
(Trypsin)
6 LEU T 137
GLY T  19
ASP T 189
GLY T 142
PRO T 198
ILE T 138
None
None
ZEN  T   1 ( 3.8A)
None
None
None
1.21A 2nmzA-1j17T:
undetectable
2nmzA-1j17T:
17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j3n 3-OXOACYL-(ACYL-CARR
IER PROTEIN)
SYNTHASE II


(Thermus
thermophilus)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
6 LEU A 236
ALA A  11
ILE A 336
GLY A 232
ALA A 348
ILE A 349
None
1.42A 2nmzA-1j3nA:
undetectable
2nmzA-1j3nA:
13.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l5j ACONITATE HYDRATASE
2


(Escherichia
coli)
PF00330
(Aconitase)
PF06434
(Aconitase_2_N)
PF11791
(Aconitase_B_N)
5 GLY A 721
ALA A 720
GLY A 715
ILE A 714
ILE A 707
None
0.85A 2nmzA-1l5jA:
undetectable
2nmzA-1l5jA:
9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ldn L-LACTATE
DEHYDROGENASE


(Geobacillus
stearothermophilus)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
6 LEU A 321
ASP A 141
GLY A 162
ILE A 189
ALA A 318
ILE A 287
None
1.26A 2nmzA-1ldnA:
undetectable
2nmzA-1ldnA:
16.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1m3u 3-METHYL-2-OXOBUTANO
ATE
HYDROXYMETHYLTRANSFE
RASE


(Escherichia
coli)
PF02548
(Pantoate_transf)
6 LEU A 187
ALA A 167
ILE A 197
GLY A 135
ALA A 188
ILE A 191
None
1.20A 2nmzA-1m3uA:
undetectable
2nmzA-1m3uA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mpp PEPSIN

(Rhizomucor
pusillus)
PF00026
(Asp)
5 LEU A  30
ASP A  32
GLY A  34
ASP A  37
ILE A 120
None
0.65A 2nmzA-1mppA:
7.1
2nmzA-1mppA:
14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1o0w RIBONUCLEASE III

(Thermotoga
maritima)
PF00035
(dsrm)
PF14622
(Ribonucleas_3_3)
5 LEU A 125
GLY A 117
GLY A 110
ALA A 128
ILE A 124
None
0.83A 2nmzA-1o0wA:
undetectable
2nmzA-1o0wA:
17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p43 ENOLASE 1

(Saccharomyces
cerevisiae)
PF00113
(Enolase_C)
PF03952
(Enolase_N)
6 LEU A 105
ASP A  97
GLY A  98
ILE A 349
ALA A 109
ILE A 110
None
1.48A 2nmzA-1p43A:
undetectable
2nmzA-1p43A:
12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pix GLUTACONYL-COA
DECARBOXYLASE A
SUBUNIT


(Acidaminococcus
fermentans)
PF01039
(Carboxyl_trans)
5 LEU A 146
GLY A 189
ALA A 211
GLY A 252
ILE A 187
None
0.85A 2nmzA-1pixA:
undetectable
2nmzA-1pixA:
11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q7h CONSERVED
HYPOTHETICAL PROTEIN


(Thermoplasma
acidophilum)
PF01472
(PUA)
PF09183
(DUF1947)
6 LEU A  84
GLY A  78
ALA A  79
ILE A  94
ALA A 118
ILE A  83
None
1.29A 2nmzA-1q7hA:
undetectable
2nmzA-1q7hA:
21.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
None
0.77A 2nmzA-1q9pA:
10.1
2nmzA-1q9pA:
98.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rrm LACTALDEHYDE
REDUCTASE


(Escherichia
coli)
PF00465
(Fe-ADH)
6 GLY A  67
ASP A  39
ILE A  95
ILE A 107
ALA A  63
ILE A  64
None
APR  A 389 (-2.7A)
None
None
None
None
1.26A 2nmzA-1rrmA:
undetectable
2nmzA-1rrmA:
16.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
None
1.30A 2nmzA-1sivA:
18.5
2nmzA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.44A 2nmzA-1sivA:
18.5
2nmzA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
None
0.91A 2nmzA-1sivA:
18.5
2nmzA-1sivA:
51.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tlg POLYANDROCARPA
LECTIN


(Polyandrocarpa
misakiensis)
PF00059
(Lectin_C)
5 LEU A  81
GLY A  56
ALA A  57
ASP A  58
GLY A  72
None
0.84A 2nmzA-1tlgA:
undetectable
2nmzA-1tlgA:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to6 GLYCERATE KINASE

(Neisseria
meningitidis)
PF02595
(Gly_kinase)
5 ALA A 190
ASP A 191
GLY A 244
ILE A 247
ILE A 259
None
None
SO4  A 373 (-3.5A)
None
None
0.81A 2nmzA-1to6A:
undetectable
2nmzA-1to6A:
16.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uaa PROTEIN
(ATP-DEPENDENT DNA
HELICASE REP.)


(Escherichia
coli)
PF00580
(UvrD-helicase)
PF13361
(UvrD_C)
5 LEU A 630
ALA A 596
ILE A 291
ILE A 283
PRO A 634
None
0.86A 2nmzA-1uaaA:
undetectable
2nmzA-1uaaA:
10.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1up2 CELA1 PROTEIN

(Mycobacterium
tuberculosis)
PF01341
(Glyco_hydro_6)
5 GLY A 246
ALA A 245
ILE A 302
ALA A 290
ILE A 291
None
0.88A 2nmzA-1up2A:
undetectable
2nmzA-1up2A:
14.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vdw HYPOTHETICAL PROTEIN
PH1897


(Pyrococcus
horikoshii)
PF00459
(Inositol_P)
6 LEU A 244
ILE A 193
GLY A 159
ILE A 163
ALA A 189
ILE A 248
None
None
EDO  A1003 (-3.8A)
None
None
None
1.23A 2nmzA-1vdwA:
undetectable
2nmzA-1vdwA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vli SPORE COAT
POLYSACCHARIDE
BIOSYNTHESIS PROTEIN
SPSE


(Bacillus
subtilis)
PF03102
(NeuB)
PF08666
(SAF)
6 GLY A 315
ALA A 349
ASP A 363
ILE A 359
ALA A 310
ILE A 312
None
1.46A 2nmzA-1vliA:
undetectable
2nmzA-1vliA:
13.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w1k VANILLYL-ALCOHOL
OXIDASE


(Penicillium
simplicissimum)
PF01565
(FAD_binding_4)
PF02913
(FAD-oxidase_C)
6 ASP A 288
GLY A 287
ILE A 296
GLY A 433
ALA A 377
ILE A 378
None
1.42A 2nmzA-1w1kA:
undetectable
2nmzA-1w1kA:
11.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1woq INORGANIC
POLYPHOSPHATE/ATP-GL
UCOMANNOKINASE


(Arthrobacter
sp. KM)
PF00480
(ROK)
6 LEU A 246
GLY A 254
ALA A 126
ASP A 123
ILE A 158
ALA A 244
None
None
None
BGC  A 290 (-2.9A)
None
None
1.32A 2nmzA-1woqA:
undetectable
2nmzA-1woqA:
18.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1z8l GLUTAMATE
CARBOXYPEPTIDASE II


(Homo sapiens)
PF02225
(PA)
PF04253
(TFR_dimer)
PF04389
(Peptidase_M28)
5 LEU A 362
ALA A 588
ILE A 450
GLY A 582
ILE A 416
None
0.83A 2nmzA-1z8lA:
undetectable
2nmzA-1z8lA:
9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zap SECRETED ASPARTIC
PROTEINASE


(Candida
albicans)
PF00026
(Asp)
5 ASP A  32
GLY A  34
ASP A  37
GLY A  83
ILE A 123
A70  A 500 ( 2.7A)
A70  A 500 (-3.8A)
None
None
A70  A 500 (-4.8A)
0.84A 2nmzA-1zapA:
7.5
2nmzA-1zapA:
16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zap SECRETED ASPARTIC
PROTEINASE


(Candida
albicans)
PF00026
(Asp)
5 LEU A 216
ASP A 218
GLY A 220
ALA A 303
ILE A 305
None
A70  A 500 ( 2.3A)
A70  A 500 (-3.3A)
A70  A 500 ( 3.8A)
A70  A 500 (-4.8A)
0.79A 2nmzA-1zapA:
7.5
2nmzA-1zapA:
16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zkd DUF185

(Rhodopseudomonas
palustris)
PF02636
(Methyltransf_28)
5 LEU A 225
ASP A 221
ASP A 279
ALA A 228
ILE A 224
None
0.87A 2nmzA-1zkdA:
undetectable
2nmzA-1zkdA:
14.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bb0 IMIDAZOLONEPROPIONAS
E


(Bacillus
subtilis)
PF01979
(Amidohydro_1)
6 LEU A 374
GLY A 409
ILE A   5
ILE A  65
ALA A  50
ILE A  47
None
1.15A 2nmzA-2bb0A:
undetectable
2nmzA-2bb0A:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bc0 NADH OXIDASE

(Streptococcus
pyogenes)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 GLY A 453
ALA A 454
ASP A 456
ILE A 387
ILE A 426
None
0.71A 2nmzA-2bc0A:
undetectable
2nmzA-2bc0A:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c07 3-OXOACYL-(ACYL-CARR
IER PROTEIN)
REDUCTASE


(Plasmodium
falciparum)
PF13561
(adh_short_C2)
6 GLY A 116
ASP A 101
ASP A 105
GLY A  72
ALA A  84
ILE A 107
None
None
None
SO4  A   2 (-3.3A)
None
None
1.31A 2nmzA-2c07A:
undetectable
2nmzA-2c07A:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewn BIRA BIFUNCTIONAL
PROTEIN


(Escherichia
coli)
PF02237
(BPL_C)
PF03099
(BPL_LplA_LipB)
PF08279
(HTH_11)
5 GLY A 186
ALA A 185
GLY A 154
ILE A 153
ILE A 207
BTX  A 501 (-3.3A)
None
None
None
None
0.73A 2nmzA-2ewnA:
undetectable
2nmzA-2ewnA:
19.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
PRO A  86
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
0.97A 2nmzA-2fmbA:
15.0
2nmzA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
0.45A 2nmzA-2fmbA:
15.0
2nmzA-2fmbA:
33.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g3n ALPHA-GLUCOSIDASE

(Sulfolobus
solfataricus)
PF01055
(Glyco_hydro_31)
PF13802
(Gal_mutarotas_2)
5 GLY A 115
ILE A 102
GLY A  66
ILE A  65
PRO A 528
None
0.70A 2nmzA-2g3nA:
undetectable
2nmzA-2g3nA:
8.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hiv THERMOSTABLE DNA
LIGASE


(Sulfolobus
solfataricus)
PF01068
(DNA_ligase_A_M)
PF04675
(DNA_ligase_A_N)
PF04679
(DNA_ligase_A_C)
6 LEU A 222
GLY A 188
ALA A 184
ASP A 181
ALA A 200
ILE A 197
None
1.49A 2nmzA-2hivA:
undetectable
2nmzA-2hivA:
12.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hpg ABC TRANSPORTER,
PERIPLASMIC
SUBSTRATE-BINDING
PROTEIN


(Thermotoga
maritima)
PF03480
(DctP)
5 LEU A 123
GLY A 272
ILE A 279
ALA A 119
ILE A 120
None
0.86A 2nmzA-2hpgA:
undetectable
2nmzA-2hpgA:
14.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2i1n DISCS, LARGE HOMOLOG
3


(Homo sapiens)
PF00595
(PDZ)
6 GLY A 142
ALA A 171
ASP A 174
ILE A 132
ILE A 145
ILE A 165
None
1.33A 2nmzA-2i1nA:
undetectable
2nmzA-2i1nA:
16.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2isq CYSTEINE SYNTHASE

(Arabidopsis
thaliana)
PF00291
(PALP)
5 GLY A 190
ALA A 189
GLY A 183
ILE A 180
PRO A 296
None
None
PLP  A 400 (-3.4A)
PLP  A 400 (-4.9A)
PLP  A 400 (-4.0A)
0.65A 2nmzA-2isqA:
undetectable
2nmzA-2isqA:
15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jfd FATTY ACID SYNTHASE

(Homo sapiens)
PF00698
(Acyl_transf_1)
PF16197
(KAsynt_C_assoc)
6 LEU A 567
ALA A 590
ASP A 591
GLY A 579
ILE A 495
ILE A 564
None
1.30A 2nmzA-2jfdA:
undetectable
2nmzA-2jfdA:
13.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qg1 MULTIPLE PDZ DOMAIN
PROTEIN


(Homo sapiens)
PF00595
(PDZ)
6 GLY A1737
ALA A1760
ASP A1763
ILE A1726
ILE A1740
ILE A1754
None
1.32A 2nmzA-2qg1A:
undetectable
2nmzA-2qg1A:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3


(Mus musculus)
PF00069
(Pkinase)
6 GLY A 594
ALA A 597
ASP A 596
ASP A 600
GLY A 534
ALA A 671
None
1.11A 2nmzA-2qr7A:
undetectable
2nmzA-2qr7A:
16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qzw CANDIDAPEPSIN-1

(Candida
albicans)
PF00026
(Asp)
5 LEU A 216
ASP A 218
GLY A 220
ALA A 303
ILE A 305
None
0.80A 2nmzA-2qzwA:
7.5
2nmzA-2qzwA:
14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r2w PLASMINOGEN
ACTIVATOR, UROKINASE


(Homo sapiens)
PF00089
(Trypsin)
6 GLY U  44
ALA U  31
ILE U  24
ILE U 121
PRO U 114
ALA U 112
None
1.17A 2nmzA-2r2wU:
undetectable
2nmzA-2r2wU:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rag DIPEPTIDASE

(Caulobacter
vibrioides)
PF01244
(Peptidase_M19)
6 LEU A 268
ALA A 248
ASP A 226
ILE A 404
ALA A 350
ILE A 278
None
1.47A 2nmzA-2ragA:
undetectable
2nmzA-2ragA:
12.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rgj FLAVIN-CONTAINING
MONOOXYGENASE


(Pseudomonas
aeruginosa)
PF01494
(FAD_binding_3)
6 LEU A 328
GLY A 322
ALA A 323
ILE A 104
ALA A  56
ILE A 327
None
FAD  A 403 (-3.9A)
FAD  A 403 (-3.2A)
None
None
None
1.33A 2nmzA-2rgjA:
undetectable
2nmzA-2rgjA:
16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ri6 2-HYDROXY-6-OXO-6-PH
ENYLHEXA-2,4-DIENOAT
E HYDROLASE


(Paraburkholderia
xenovorans)
PF12697
(Abhydrolase_6)
5 LEU A 283
GLY A  63
ALA A  62
GLY A  57
ILE A 280
None
0.85A 2nmzA-2ri6A:
undetectable
2nmzA-2ri6A:
16.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ALA A  82
ILE A  84
None
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 (-4.2A)
AB1  A 501 (-3.6A)
AB1  A 501 ( 4.2A)
0.98A 2nmzA-2rkfA:
20.9
2nmzA-2rkfA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
1.47A 2nmzA-2rkfA:
20.9
2nmzA-2rkfA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ALA A  82
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 (-3.6A)
AB1  A 501 ( 4.2A)
0.52A 2nmzA-2rkfA:
20.9
2nmzA-2rkfA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 LEU A  35
ASP A  37
ALA A  40
ASP A  41
ILE A  71
ILE A 108
None
1.28A 2nmzA-2rspA:
12.9
2nmzA-2rspA:
33.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2uv8 FATTY ACID SYNTHASE
SUBUNIT BETA (FAS1)


(Saccharomyces
cerevisiae)
PF00698
(Acyl_transf_1)
PF01575
(MaoC_dehydratas)
PF08354
(DUF1729)
PF13452
(MaoC_dehydrat_N)
PF16073
(SAT)
5 GLY G 621
ALA G 620
ILE G 617
GLY G 648
ILE G 676
None
FMN  G3051 ( 4.7A)
None
None
None
0.87A 2nmzA-2uv8G:
undetectable
2nmzA-2uv8G:
4.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2v8n LACTOSE PERMEASE

(Escherichia
coli)
PF01306
(LacY_symp)
5 LEU A  76
GLY A 115
PRO A 123
ALA A 124
ILE A  80
None
0.85A 2nmzA-2v8nA:
undetectable
2nmzA-2v8nA:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vdc GLUTAMATE SYNTHASE
[NADPH] LARGE CHAIN


(Azospirillum
brasilense)
PF00310
(GATase_2)
PF01493
(GXGXG)
PF01645
(Glu_synthase)
PF04898
(Glu_syn_central)
6 LEU A1286
GLY A1273
ALA A1272
ASP A1291
ILE A1322
GLY A1324
None
1.44A 2nmzA-2vdcA:
undetectable
2nmzA-2vdcA:
6.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wsk GLYCOGEN DEBRANCHING
ENZYME


(Escherichia
coli)
PF00128
(Alpha-amylase)
PF02922
(CBM_48)
5 LEU A 188
GLY A 255
ALA A 254
ILE A 248
ILE A 185
None
0.84A 2nmzA-2wskA:
undetectable
2nmzA-2wskA:
8.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zuf ARGINYL-TRNA
SYNTHETASE


(Pyrococcus
horikoshii)
PF00750
(tRNA-synt_1d)
PF03485
(Arg_tRNA_synt_N)
PF05746
(DALR_1)
6 LEU A 620
GLY A 564
ALA A 563
ASP A 566
ALA A 617
ILE A 572
None
None
None
A  B 917 ( 4.9A)
None
None
1.13A 2nmzA-2zufA:
undetectable
2nmzA-2zufA:
10.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqc COMPONENT B OF
HEXAPRENYL
DIPHOSPHATE SYNTHASE


(Micrococcus
luteus)
PF00348
(polyprenyl_synt)
5 ASP B 211
ASP B 212
ILE B 167
GLY B 204
ILE B 203
MG  B 328 (-3.1A)
None
None
None
None
0.81A 2nmzA-3aqcB:
undetectable
2nmzA-3aqcB:
18.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b1r RIBOKINASE, PUTATIVE

(Burkholderia
thailandensis)
PF00294
(PfkB)
6 GLY A 142
ASP A 144
ILE A   9
GLY A  48
ALA A  64
ILE A   5
None
None
None
AMP  A 501 (-3.3A)
None
None
1.43A 2nmzA-3b1rA:
undetectable
2nmzA-3b1rA:
15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ecd SERINE
HYDROXYMETHYLTRANSFE
RASE 2


(Burkholderia
pseudomallei)
PF00464
(SHMT)
5 LEU A 295
GLY A 216
ALA A 215
PRO A 370
ILE A 291
None
0.79A 2nmzA-3ecdA:
undetectable
2nmzA-3ecdA:
14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eo7 PUTATIVE
NITROREDUCTASE


(Trichormus
variabilis)
PF00881
(Nitroreductase)
6 ALA A 230
ASP A 214
GLY A 210
PRO A 235
ALA A 162
ILE A 164
None
1.45A 2nmzA-3eo7A:
undetectable
2nmzA-3eo7A:
11.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fbs OXIDOREDUCTASE

(Agrobacterium
fabrum)
PF07992
(Pyr_redox_2)
5 GLY A 284
ALA A  17
ILE A  66
GLY A  22
ILE A   7
None
0.84A 2nmzA-3fbsA:
undetectable
2nmzA-3fbsA:
17.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gf7 GLUTACONYL-COA
DECARBOXYLASE
SUBUNIT A


([Clostridium]
symbiosum)
PF01039
(Carboxyl_trans)
5 LEU A 148
GLY A 191
ALA A 213
GLY A 256
ILE A 189
None
0.85A 2nmzA-3gf7A:
undetectable
2nmzA-3gf7A:
10.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gh8 IODOTYROSINE
DEHALOGENASE 1


(Mus musculus)
PF00881
(Nitroreductase)
5 LEU A 256
GLY A 218
ILE A 116
GLY A 120
ILE A 190
None
0.84A 2nmzA-3gh8A:
undetectable
2nmzA-3gh8A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gk0 PYRIDOXINE
5'-PHOSPHATE
SYNTHASE


(Burkholderia
pseudomallei)
PF03740
(PdxJ)
6 LEU A 213
ALA A 198
ILE A 221
GLY A 201
ALA A 209
ILE A 210
None
1.39A 2nmzA-3gk0A:
undetectable
2nmzA-3gk0A:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gve YFKN PROTEIN

(Bacillus
subtilis)
PF00149
(Metallophos)
5 GLY A 121
ALA A 122
ASP A 123
ILE A  89
ILE A 126
None
0.66A 2nmzA-3gveA:
undetectable
2nmzA-3gveA:
14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gzs UNCHARACTERIZED SUSD
SUPERFAMILY PROTEIN


(Bacteroides
fragilis)
PF12741
(SusD-like)
5 ASP A 419
GLY A 302
ILE A 305
PRO A 430
ALA A 429
None
0.77A 2nmzA-3gzsA:
undetectable
2nmzA-3gzsA:
10.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hhd FATTY ACID SYNTHASE

(Homo sapiens)
PF00109
(ketoacyl-synt)
PF00698
(Acyl_transf_1)
PF02801
(Ketoacyl-synt_C)
PF16197
(KAsynt_C_assoc)
6 LEU A 567
ALA A 590
ASP A 591
GLY A 579
ILE A 495
ILE A 564
None
1.34A 2nmzA-3hhdA:
undetectable
2nmzA-3hhdA:
7.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
6 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
ILE A 224
None
1.07A 2nmzA-3i5gA:
undetectable
2nmzA-3i5gA:
8.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iay DNA POLYMERASE DELTA
CATALYTIC SUBUNIT


(Saccharomyces
cerevisiae)
PF00136
(DNA_pol_B)
PF03104
(DNA_pol_B_exo1)
5 ASP A 976
GLY A 975
ALA A 971
ILE A 811
GLY A 598
None
0.86A 2nmzA-3iayA:
undetectable
2nmzA-3iayA:
8.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3igx TRANSALDOLASE

(Francisella
tularensis)
PF00923
(TAL_FSA)
6 LEU A 158
GLY A 174
ALA A 173
ILE A 280
ALA A 138
ILE A 143
None
1.41A 2nmzA-3igxA:
undetectable
2nmzA-3igxA:
16.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j7a 40S RIBOSOMAL
PROTEIN ES6


(Plasmodium
falciparum)
PF01092
(Ribosomal_S6e)
5 LEU H 111
GLY H  55
ILE H 101
GLY H 103
ILE H  52
None
G  A 160 ( 3.9A)
None
None
None
0.83A 2nmzA-3j7aH:
undetectable
2nmzA-3j7aH:
16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jv7 ADH-A

(Rhodococcus
ruber)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 211
GLY A 216
ALA A 217
ASP A 218
ILE A 190
None
0.77A 2nmzA-3jv7A:
undetectable
2nmzA-3jv7A:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k9t PUTATIVE PEPTIDASE

(Clostridium
acetobutylicum)
PF09940
(DUF2172)
PF16221
(HTH_47)
PF16254
(DUF4910)
5 LEU A 202
ALA A 207
ILE A 181
ALA A 250
ILE A 203
None
0.87A 2nmzA-3k9tA:
undetectable
2nmzA-3k9tA:
12.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3khz PUTATIVE DIPEPTIDASE
SACOL1801


(Staphylococcus
aureus)
PF01546
(Peptidase_M20)
6 LEU A 130
GLY A  73
ALA A  72
GLY A  80
ALA A 126
ILE A 127
None
1.00A 2nmzA-3khzA:
undetectable
2nmzA-3khzA:
12.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kl7 PUTATIVE
METAL-DEPENDENT
HYDROLASE


(Parabacteroides
distasonis)
PF13483
(Lactamase_B_3)
5 LEU A 156
GLY A 153
ASP A 120
ILE A  77
ILE A 130
None
0.83A 2nmzA-3kl7A:
undetectable
2nmzA-3kl7A:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l7n PUTATIVE
UNCHARACTERIZED
PROTEIN


(Streptococcus
mutans)
PF00117
(GATase)
5 LEU A  49
GLY A  89
GLY A  98
ALA A  80
ILE A  87
None
0.81A 2nmzA-3l7nA:
undetectable
2nmzA-3l7nA:
16.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lez BETA-LACTAMASE

(Oceanobacillus
iheyensis)
PF13354
(Beta-lactamase2)
5 ALA A  64
ILE A 262
GLY A 260
ILE A 259
ALA A 294
None
0.83A 2nmzA-3lezA:
undetectable
2nmzA-3lezA:
16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdo PUTATIVE
PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
CYCLO-LIGASE


(Parabacteroides
distasonis)
PF02769
(AIRS_C)
6 LEU A 251
GLY A 256
ALA A 255
ASP A 246
ILE A 319
ILE A 248
None
1.04A 2nmzA-3mdoA:
undetectable
2nmzA-3mdoA:
13.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
None
1.00A 2nmzA-3mwsA:
19.5
2nmzA-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.38A 2nmzA-3mwsA:
19.5
2nmzA-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  48
PRO A  81
ILE A  84
None
1.38A 2nmzA-3mwsA:
19.5
2nmzA-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
None
0.64A 2nmzA-3mwsA:
19.5
2nmzA-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.47A 2nmzA-3mwsA:
19.5
2nmzA-3mwsA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oum TOXOFLAVIN-DEGRADING
ENZYME


(Paenibacillus
polymyxa)
PF00903
(Glyoxalase)
6 LEU A   7
GLY A 137
ASP A 177
GLY A 174
ILE A 173
ILE A   4
None
1.47A 2nmzA-3oumA:
undetectable
2nmzA-3oumA:
20.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q4g NH(3)-DEPENDENT
NAD(+) SYNTHETASE


(Vibrio cholerae)
PF02540
(NAD_synthase)
6 LEU A  42
GLY A  47
ASP A  87
PRO A 100
ALA A  77
ILE A  44
None
CA  A 279 (-3.6A)
None
None
None
None
1.49A 2nmzA-3q4gA:
undetectable
2nmzA-3q4gA:
16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qlj SHORT CHAIN
DEHYDROGENASE


(Mycobacterium
avium)
PF00106
(adh_short)
5 LEU A  24
GLY A  15
ALA A  14
ILE A  10
ALA A  27
None
0.80A 2nmzA-3qljA:
undetectable
2nmzA-3qljA:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rl7 DISKS LARGE HOMOLOG
1


(Homo sapiens)
no annotation 6 GLY B 235
ALA B 264
ASP B 267
ILE B 225
ILE B 238
ILE B 258
None
1.42A 2nmzA-3rl7B:
undetectable
2nmzA-3rl7B:
14.95